Abstracts tagged "Fibromyalgia and pediatric rheumatology"

Abstract Number: 122 • 2017 Pediatric Rheumatology Symposium
Presenting Manifestations of Amplified Musculoskeletal Pain Syndrome in Males versus Females
Sabrina Gmuca¹, Jenna L. Tress², Jennifer Mosby³, Laura P. Richardson³ and David D. Sherry², ¹Pediatric Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA, ²Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ³Seattle Children's Hospital, Seattle, WA
Background/Purpose: Amplified musculoskeletal pain syndrome (AMPS) is a chronic non-inflammatory musculoskeletal pain condition. AMPS has a predilection for females but males can be affected as…
Abstract Number: 2271 • 2014 ACR/ARHP Annual Meeting
Symptom and Treatment Characteristics of Juvenile Primary Fibromyalgia Syndrome: Are Males and Females Created Equal?
Jennifer E. Weiss¹, Kenneth N. Schikler², Alexis Boneparth³, Cara Hoffart⁴, Mark Connelly⁵ and The CARRA Registry Investigators⁶, ¹Pediatric Rheumatology, Joseph M Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack, NJ, ²Department of Pediatrics, Univ of Louisville Schl of Med, Louisville, KY, ³Pediatric Rheumatology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, ⁴Rheumatology and Integrative Pain Management, Children's Mercy Hospital, Kansas City, MO, ⁵Children's Mercy Hospital, Kansas City, MO, ⁶Childhood Arthritis and Rheumatology Research Alliance, Durham, NC
Background/Purpose Children and adolescents with persistent widespread musculoskeletal pain frequently present to pediatric rheumatologists for evaluation. Limited data are available on the characteristics and treatments…
Abstract Number: 1104 • 2014 ACR/ARHP Annual Meeting
Utility of the 2010 ACR Diagnostic Criteria for Fibromyalgia for Pediatric Patients with Juvenile Fibromyalgia
Tracy Ting¹, Kimberly Barnett², Anne Lynch-Jordan³ and Susmita Kashikar-Zuck², ¹Rheumatology/MLC 4010, Cincinnati Children's Hosp, Cincinnati, OH, ²Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Background/Purpose Juvenile Fibromyalgia (JFM) is a chronic condition characterized by widespread musculoskeletal pain, fatigue, poor sleep and significant morbidity. Currently, a classification of JFM is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].